Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Biomarker driven clinical trials

Dr Oleg Gluz - West German Study Group Monchengladbach, Germany
Biomarker driven clinical trials ( Dr Oleg Gluz - West German Study Group Monchengladbach, Germany )
20 Dec 2016

A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer

Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016

Five years of letrozole does not improve disease free survival for pretreated HR positive breast cancer

Dr Terry Mamounas - UF Health Center, Orlando, USA
Five years of letrozole does not improve disease free survival for pretreated HR positive breast cancer ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
14 Dec 2016

Reducing chemo-associated hair loss with scalp cooling cap

Dr Julie Rani Nangia - Baylor College of Medicine, Houston, USA
Reducing chemo-associated hair loss with scalp cooling cap ( Dr Julie Rani Nangia - Baylor College of Medicine, Houston, USA )
14 Dec 2016

Decoding breast cancer predisposition genes

Dr Fergus Couch - Mayo Clinic, Rochester, USA
Decoding breast cancer predisposition genes ( Dr Fergus Couch - Mayo Clinic, Rochester, USA )
14 Dec 2016

Macrophage iron recycling in triple negative breast cancer

Dr Lisa Privette Vinnedge - Cincinnati Children's Hospital, Cincinnati, USA
Macrophage iron recycling in triple negative breast cancer ( Dr Lisa Privette Vinnedge - Cincinnati Children's Hospital, Cincinnati, USA )
14 Dec 2016

Results of the BELLE-3 study of buparlisib for advanced breast cancer

Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
Results of the BELLE-3 study of buparlisib for advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016

Epirubicin and cyclophosphamide before docetaxel in early breast cancer

Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark
Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )
14 Dec 2016

Matched mutations and long term letrozole for breast cancer

Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA
Matched mutations and long term letrozole for breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA )
14 Dec 2016

neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
13 Dec 2016

Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer

Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
13 Dec 2016

No benefit for adjuvant ibandronate at 3 years in early breast cancer

Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
No benefit for adjuvant ibandronate at 3 years in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
13 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation